MMF Influence on HCV Viral Evolution After Liver Transplantation

Mayo Clinic17 enrolled

Overview

Samples from a large clinical trial comparing three immunosuppression regimens, two of which contained MMF, are used to identify the HCV viral quasispecies behaviour after liver transplantation

Study Type

OBSERVATIONAL

Enrollment

Conditions

HCV Infection Liver Transplantation

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

All patients enrolled into - An Open Randomized, Prospective Multicenter Study to Compare the Efficacy and Safety Among Three Immunosuppressant Treatment Regimens in Patients Receiving a Liver Transplant for End-Stage Liver Disease Caused by Chronic Hepatitis C Infection

Locations (1)

Mayo Clinic

Scottsdale, Arizona, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.